{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:49:15Z","timestamp":1790250555306,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"National Science and Technology Major Project of China","award":["2013ZX10002005"],"award-info":[{"award-number":["2013ZX10002005"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671998"],"award-info":[{"award-number":["81671998"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Science and Technology Commission","award":["16411960100"],"award-info":[{"award-number":["16411960100"]}]},{"name":"key scientific research project of Shanghai municipal health and Family Planning Commission","award":["20134032"],"award-info":[{"award-number":["20134032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12876-017-0703-9","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T07:29:49Z","timestamp":1512372589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B"],"prefix":"10.1186","volume":"17","author":[{"given":"Zhan-Qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1286-7280","authenticated-orcid":false,"given":"Xiao-Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Cheng","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"703_CR1","unstructured":"WHO: Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection.; 2015."},{"issue":"4","key":"703_CR2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2010.01.007","volume":"52","author":"T Nguyen","year":"2010","unstructured":"Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, Levy M, Locarnini SA, Hepatitis B. Surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol. 2010;52(4):508\u201313.","journal-title":"J Hepatol"},{"issue":"6","key":"703_CR3","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/hep.23571","volume":"51","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, Slavin J, Bowden S, Gane EJ, Abbott W, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology. 2010;51(6):1933\u201344.","journal-title":"Hepatology"},{"issue":"3","key":"703_CR4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1172\/JCI83339","volume":"126","author":"X Zhang","year":"2016","unstructured":"Zhang X, Lu W, Zheng Y, Wang W, Bai L, Chen L, Feng Y, Zhang Z, Yuan Z. In Situ analysis of intrahepatic virological events in chronic hepatitis B virus infection. J Clin Invest. 2016;126(3):1079\u201392.","journal-title":"J Clin Invest"},{"issue":"2","key":"703_CR5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/JCM.40.2.439-445.2002","volume":"40","author":"T Kimura","year":"2002","unstructured":"Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, Maki N. Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol. 2002;40(2):439\u201345.","journal-title":"J Clin Microbiol"},{"issue":"23","key":"703_CR6","doi-asserted-by":"crossref","first-page":"21713","DOI":"10.1074\/jbc.M501564200","volume":"280","author":"T Kimura","year":"2005","unstructured":"Kimura T, Ohno N, Terada N, Rokuhara A, Matsumoto A, Yagi S, Tanaka E, Kiyosawa K, Ohno S, Maki N, Hepatitis B. Virus DNA-negative dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain. J Biol Chem. 2005;280(23):21713\u20139.","journal-title":"J Biol Chem"},{"issue":"4","key":"703_CR7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2893.2003.00437.x","volume":"10","author":"A Rokuhara","year":"2003","unstructured":"Rokuhara A, Tanaka E, Matsumoto A, Kimura T, Yamaura T, Orii K, Sun X, Yagi S, Maki N, Kiyosawa K. Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment. J Viral Hepat. 2003;10(4):324\u201330.","journal-title":"J Viral Hepat"},{"issue":"1","key":"703_CR8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jmv.21339","volume":"81","author":"F Suzuki","year":"2009","unstructured":"Suzuki F, Miyakoshi H, Kobayashi M, Kumada H. Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients. J Med Virol. 2009;81(1):27\u201333.","journal-title":"J Med Virol"},{"key":"703_CR9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jviromet.2016.05.016","volume":"235","author":"ZQ Zhang","year":"2016","unstructured":"Zhang ZQ, Lu W, Wang YB, Weng QC, Zhang ZY, Yang ZQ, Feng YL. Measurement of the hepatitis B core-related antigen is valuable for predicting the pathological status of liver tissues in chronic hepatitis B patients. J Virol Methods. 2016;235:92\u20138.","journal-title":"J Virol Methods"},{"issue":"4","key":"703_CR10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"ZD Goodman","year":"2007","unstructured":"Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47(4):598\u2013607.","journal-title":"J Hepatol"},{"issue":"4","key":"703_CR11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1083\/jcb.106.4.1093","volume":"106","author":"PD Garcia","year":"1988","unstructured":"Garcia PD, JH O, Rutter WJ, Walter P. Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J Cell Biol. 1988;106(4):1093\u2013104.","journal-title":"J Cell Biol"},{"issue":"8","key":"703_CR12","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1128\/JVI.02348-08","volume":"83","author":"K Ito","year":"2009","unstructured":"Ito K, Kim KH, Lok AS, Tong S. Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme. J Virol. 2009;83(8):3507\u201317.","journal-title":"J Virol"},{"issue":"9","key":"703_CR13","doi-asserted-by":"crossref","first-page":"e1002255","DOI":"10.1371\/journal.ppat.1002255","volume":"7","author":"X Ning","year":"2011","unstructured":"Ning X, Nguyen D, Mentzer L, Adams C, Lee H, Ashley R, Hafenstein S, Hu J. Secretion of genome-free hepatitis B virus--single strand blocking model for virion morphogenesis of para-retrovirus. PLoS Pathog. 2011;7(9):e1002255.","journal-title":"PLoS Pathog"},{"key":"703_CR14","doi-asserted-by":"crossref","unstructured":"van Campenhout MJ, Brouwer WP, van Oord GW, Xie Q, Zhang Q, Zhang N, Guo S, Tabak F, Streinu-Cercel A, Wang J, et al. Hepatitis B core-related antigen levels are associated with response to entecavir and Peginterferon add-on therapy in Hbeag-positive chronic hepatitis B patients. Clin Microbiol Infect. 2016;22(6):571.e5\u20139.","DOI":"10.1016\/j.cmi.2016.02.002"},{"issue":"7","key":"703_CR15","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/infdis\/jiv572","volume":"213","author":"M Honda","year":"2016","unstructured":"Honda M, Shirasaki T, Terashima T, Kawaguchi K, Nakamura M, Oishi N, Wang X, Shimakami T, Okada H, Arai K, et al. Hepatitis B virus (HBV) Core-related antigen during Nucleos(t)ide analog therapy is related to intra-hepatic HBV replication and development of hepatocellular carcinoma. J Infect Dis. 2016;213(7):1096\u2013106.","journal-title":"J Infect Dis"},{"issue":"2","key":"703_CR16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L: EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398.","journal-title":"J Hepatol"},{"issue":"4","key":"703_CR17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jmv.1890290408","volume":"29","author":"G Gerken","year":"1989","unstructured":"Gerken G, Manns M, Gerlich WH, Hess G, Meyer zum Buschenfelde KH. Immune blot analysis of viral surface proteins in serum and liver of patients with chronic hepatitis B virus infection. J Med Virol. 1989;29(4):261\u20135.","journal-title":"J Med Virol"},{"issue":"5","key":"703_CR18","first-page":"327","volume":"96","author":"S Hadziyannis","year":"1973","unstructured":"Hadziyannis S, Gerber MA, Vissoulis C, Popper H, Cytoplasmic h B. Antigen in \"ground-glass\" hepatocytes of carriers. Arch Pathol. 1973;96(5):327\u201330.","journal-title":"Arch Pathol"},{"key":"703_CR19","doi-asserted-by":"crossref","unstructured":"Maasoumy B, Wiegand SB, Jaroszewicz J, Bremer B, Lehmann P, Deterding K, Taranta A, Manns MP, Wedemeyer H, Glebe D, et al. Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D. Clin Microbiol Infect. 2015;21(6) 606 e601\u2013610","DOI":"10.1016\/j.cmi.2015.02.010"},{"issue":"11","key":"703_CR20","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/1469-0691.12739","volume":"20","author":"WK Seto","year":"2014","unstructured":"Seto WK, Wong DK, Fung J, Huang FY, Liu KS, Lai CL, Yuen MF, Linearized h B. Surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B. Clin Microbiol Infect. 2014;20(11):1173\u201380.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-017-0703-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T06:04:44Z","timestamp":1570428284000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-017-0703-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["703"],"URL":"https:\/\/doi.org\/10.1186\/s12876-017-0703-9","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"140"}}